Lataa...
TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells
Doxorubicin (Dox, Adriamycin) has been widely used in breast cancer treatment. But its severe cardio-toxic side effects limited the clinical use. Dox treatment can induce DNA damage and other accompanying effects in cancer cells, and subsequently activates nuclear factor κB (NF-κB) pathway which has...
Tallennettuna:
| Julkaisussa: | Sci Rep |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013439/ https://ncbi.nlm.nih.gov/pubmed/27599572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep32737 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|